Apr 9 2010
Svelte Medical Systems, Inc. is pleased to announce that it has successfully completed the extension of its Series A financing from institutional and private investors including CNF Investments, Apjohn Ventures and the Fischell family. The company's Series A extension was oversubscribed and included an initial investment by Norwich Ventures LP. Norwich Ventures is a seed and early-stage venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies. The firm specializes in the field of medical technologies and is uniquely positioned to work collaboratively with emerging companies. The Norwich team is made up of former industry executives and entrepreneurs based in Massachusetts and Pennsylvania.
“These are exciting events which continue to demonstrate our investor's commitment, strengthens our leadership and firmly positions us to continue with our vision to deliver a unique and much anticipated product to the coronary marketplace”
In addition, we are pleased to announce that Mr. Robert Croce former Worldwide Franchise Chairman of Cordis, a Johnson & Johnson company has joined the company's Board of Directors. Bob concluded a 36-year career at Johnson & Johnson where he held a series of senior positions, culminating with 12 years as Company Group Chairman. Bob is one of the leading experts in the Interventional cardiology and brings a tremendous wealth of sector knowledge, experience, and relationships to the company.
"These are exciting events which continue to demonstrate our investor's commitment, strengthens our leadership and firmly positions us to continue with our vision to deliver a unique and much anticipated product to the coronary marketplace", said Mark Pomeranz, President and CEO.